SOUTHWEST ONCOLOGY GROUP--CLINICAL TRIALS

参加西南肿瘤学小组(SWOG)一直是一个主要的 血液科临床调查工作的一部分- 俄克拉荷马大学医学系肿瘤学 健康科学中心(OUHSC)这一努力最终导致了入学 进入SWOG的合格和可评估患者的数量保持一致 审判。俄克拉荷马大学的SWOG协议提供了主要 俄克拉荷马州居民大规模参与的机会 设计临床试验。患者是通过父母双方积累的 机构及其附属CGOPs。该州大多数患者，包括 大量的美洲原住民和俄克拉荷马农村人受到 作为这个网络的一部分的医生。全年的年度应计项目 目前已有97名患者入网。 我们一直在努力增加我们对学术研究的参与 临床试验的几个方面。在会员机构，我们专注于 我们在五个领域的努力，包括乳腺癌，头颈部癌症， 泌尿生殖道癌、肺癌和血液系统恶性肿瘤。这 努力的结果是建立了多学科方案 在这些领域，这有助于促进识别和 根据SWOG方案登记患者。此外，它还允许 用于开发可用作试点的内部协议 对未来SWOG试验的研究。

Participation in the Southwest Oncology Group (SWOG) has been a major part of the clinical investigative effort of the section of Hematology- Oncology in the Department of Medicine at the University of Oklahoma Health Sciences Center (OUHSC). This effort results in the enrollment of a consistent number of eligible and evaluable patients into SWOG trials. SWOG protocols at the University of Oklahoma provide the major opportunity for Oklahoma residents to participate in large scale, well designed clinical trials. Patients are accrued via both the parent institution and affiliated CGOPs. Most patients in the state, including a large number of Native Americans and rural Oklahomans, are treated by physicians who are part of this network. Annual accrual for the entire network has been ninety-seven patients. We have been working to increase our involvement in the scholarly aspects of clinical trials. At the member institution, we have focused our efforts in five areas including breast cancer, head and neck cancer, genitourinary cancer, lung cancer, and hematological malignancies. This effort has resulted in the establishment of multidisciplinary programs in these areas which has helped to facilitate identification and enrollment of patients on SWOG protocols. In addition, it has allowed for the development of in-house protocols which might serve as pilot studies for future SWOG trials.